期刊
FRONTIERS IN ONCOLOGY
卷 11, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2021.648968
关键词
lymph node metastasis; bladder cancer; biomarkers; oncogenes; tumor suppressor genes
类别
资金
- National Natural Science Foundation of China [81873626, 81902592]
- Hunan Natural Science Foundation [2020JJ5884]
- Hunan Province Key RD Program [2019SK2202]
- Xiangya Hospital Youth Fund [2018Q09]
Early detection of lymph node metastasis is crucial for improving prognosis and overall survival in bladder cancer patients, but current diagnostic methods are limited. Non-coding RNA and m6A have been reported to be abnormally expressed in bladder cancer related to lymph node metastasis, offering potential for more accurate diagnostic methods in future clinical applications.
Bladder cancer is one of the leading causes of cancer deaths worldwide. Early detection of lymph node metastasis of bladder cancer is essential to improve patients' prognosis and overall survival. Current diagnostic methods are limited, so there is an urgent need for new specific biomarkers. Non-coding RNA and m6A have recently been reported to be abnormally expressed in bladder cancer related to lymph node metastasis. In this review, we tried to summarize the latest knowledge about biomarkers, which predict lymph node metastasis in bladder cancer and their mechanisms. In particular, we paid attention to the impact of non-coding RNA on lymphatic metastasis of bladder cancer and its specific molecular mechanisms, as well as some prediction models based on imaging, pathology, and biomolecules, in an effort to find more accurate diagnostic methods for future clinical application.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据